Skip to content

The Effectiveness of Tuina in Managing Chronic Non-specific Low Back Pain: A Protocol of a multi-center international Randomized Controlled Trial

The Effectiveness of Tuina in Managing Chronic Non-specific Low Back Pain: A Protocol of a multi-center international Randomized Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000040288
Enrollment
Unknown
Registered
2020-11-27
Start date
2020-12-01
Completion date
Unknown
Last updated
2022-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Non-specific Low Back Pain

Interventions

Sponsors

School of Traditional Chinese Medicine, Jinan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
21 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Pain and discomfort of unknown etiology between the costal margins and inferior gluteal folds with or without referred pain to the lower limbs), lasting for more than 12 weeks; (2) There may be waist muscle weakness, stiffness, limited mobility or reduced spinal coordination. The symptoms of pain are lessened or disappeared after bed rest. While the symptoms of pain are aggravated after bending over, sedentary, or standing for a long time; (3) Physical examination showed an increase in muscle tension or a significant localized tenderness point (trigger point) in the painful area, with negative straight-leg raising test, and no signs of nerve root lesions. (4) Patients older than 21 years and younger than 75 years of both sexes.

Exclusion criteria

Exclusion criteria: (1) Patients with low back pain associated with nerve root compromise; (2) Patients with severe skin diseases (e.g., skin cancer, erysipelas, severe eczema, severe dermatitis, severe psoriasis and severe hives lupus); (3) Serious spinal pathologies such as fractures, tumors, inflammatory and infectious diseases; (4) History of spine surgery; (5) Serious cardiovascular or metabolic disorders, such as heart failure, severe osteoporosis; (6) Patients diagnosed with cognitive issues such as major depression, and moderate to severe dementia severe psychiatric diseases (such as schizophrenia, bipolar affective disorder, paranoid psychosis); (7) Women who are pregnant, or who are of childbearing potential and are likely to become pregnant during the treatment phase but are not willing to use a reliable form of contraception, will also be excluded. Reliable forms of contraception include oral contraception, diaphragm or condom (with spermicide), injections, intrauterine device, surgical sterilization, and abstinence.

Design outcomes

Primary

MeasureTime frame
Pain;

Secondary

MeasureTime frame
ODI score;spinal ROM;SF-36 score;Adverse events;

Countries

United States

Contacts

Public ContactJiaxu Chen

School of Traditional Chinese Medicine, Jinan University

chenjiaxu@hotmail.com+86 02085221323

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 13, 2026